ReviewJournal of echocardiography2026
Periprocedural echocardiographic guidance for transcatheter paravalvular leak closure: from patient selection to follow-up.
Review in Journal of echocardiography, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paravalvular leak (PVL) after surgical valve replacement may cause heart failure, hemolytic anemia, or both. Transcatheter closure is an important therapeutic option for selected patients at high surgical risk. The irregular and often complex anatomy of PVL requires imaging assessment throughout patient selection, procedural planning, device deployment, and follow-up.Transthoracic echocardiography assesses prosthetic valve function and the hemodynamic consequences of PVL. Transesophageal echocardiography, particularly three-dimensional imaging with color Doppler, characterizes defect anatomy and guides wire crossing, device positioning, and release decisions. Assessment must address residual regurgitation, device stability, and potential interference with prosthetic valve function.Therapeutic goals depend on the dominant clinical phenotype. In heart failure-dominant PVL, sufficient reduction of regurgitant burden may improve symptoms and hemodynamics despite a small residual leak. In hemolysis-dominant PVL, residual high-velocity jets may sustain hemolysis and require additional closure. Mixed presentations require assessment of both hemodynamic and hematologic responses.Cardiac computed tomography complements echocardiography by defining channel geometry and fluoroscopic working projections, particularly when acoustic shadowing limits visualization. This review summarizes periprocedural echocardiographic assessment, emphasizing the integration of anatomical findings, clinical phenotype, and treatment response to guide procedural decisions and follow-up.
Indexed as
Identifiers
42848295What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.